Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 5/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | MGLL | Q99685 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 7/20 | 0.33 |
| ▸ | ZDHHC20 | Q5W0Z9 | 3/20 | 0.32 |
| ▸ | ZDHHC2 | Q9UIJ5 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17133217 | 0.85 | EPHX1 (0.44) | EPHX1ACHE | |
| SCHEMBL19929282 | 0.85 | EPHX1 (0.39) | EPHX1ACHELMNA | |
| SCHEMBL19929284 | 0.84 | EPHX1 (0.45) | EPHX1ACHEZDHHC20ZDHHC2LMNA | |
| SCHEMBL17133208 | 0.83 | ACHE (0.35) | EPHX1ACHELMNA | |
| SCHEMBL2565754 | 0.82 | CA14 (0.33) | EPHX1TSHR | |
| SCHEMBL3359618 | 0.81 | EPHX1 (0.45) | EPHX1MGLLACHELMNA | |
| SCHEMBL2616732 | 0.79 | EPHX1 (0.37) | EPHX1TSHRACHELMNA | |
| SCHEMBL13907622 | 0.79 | MMP2 (0.35) | EPHX1TSHRACHELMNASMN1; SMN2 | |
| SCHEMBL17828588 | 0.78 | EPHX1 (0.33) | EPHX1TSHRACHEKDM4ELMNA | |
| SCHEMBL22574055 | 0.78 | CA12 (0.38) | EPHX1TSHRLMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090075096-A1 | Organoalkoxysilanes | SIKA TECHNOLOGY AG (CH) | 2009-03-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090075096-A1 | Organoalkoxysilanes | CDH1, TST, EPCAM | EPHX1 376/4885TSHR 3707/4885MGLL 3431/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.